Skip to main content
Premium Trial:

Request an Annual Quote

Biotecon, Biotest Ink Sales Pact for PCR Pathogen Testing

NEW YORK (GenomeWeb News) – Biotest will distribute Biotecon Diagnostics' real-time PCR-based testing system for identifying microorganisms under a new, global sales agreement, Biotecon said today.

Beginning in September, Biotest's global microbiology business unit will sell Biotecon's Hygiene Screening System, which can identify Staphylococcus, Micrococcus, Kocuria, and Kytococcus in under two hours from a single bacterial colony, Biotecon said.

The company will market the system to customers in the pharmaceutical and environmental monitoring industries.

"Our customers in the pharmaceutical industry will benefit from this rapid microbiology method for the identification of bacterial colonies grown on our solid media, which are optimized for monitoring tests," Frank Schulze, executive VP of Biotest's global microbiology business unit, said in a statement.

Biotecon is based in Potsdam, Germany, and Biotest is based in Eppelheim, Germany.

The Scan

Science Confidence Boost

The New York Times reports that a new poll finds trust in science and scientists has increased with the COVID-19 pandemic.

Appeal and Funds

Some grant applications denied funding due to an Australian Research Council rule change have now been funded following an appeal, the Guardian reports.

Surveillance for Variants

Vox writes that the detection of the Omicron SARS-CoV-2 variant highlights the need for improved viral genomic surveillance.

Nature Papers Examine Taxonomic Gaps in Plant Sequencing, SARS-CoV-2-Human Interactome

In Nature this week: plant genome sequencing dominated by affluent countries, and more.